The Institute for Safe Medication Practices (ISMP) issued a warning in June to stop using dosing cups for liquid medicine that are embossed with scales for drams, ounces, teaspoon, and tablespoon measures. These measurement scales can be easily confused with the milliliter dosing scales.
In a recently published Federal Register notice, FDA threatened action against companies that manufacture or distribute certain unapproved eardrop products labeled for prescription use.
One quarter of patients prescribed opioid painkillers for the first time progress to long-term use of these medications, according to researchers at the Mayo Clinic.
Over the course of a career, errors are inevitable. For pharmacists, who never forget that lives are at stake, the prospect is chilling. Yet close calls still happen. This was one.
The American Pharmacists Association Foundation has introduced a self-management tool designed to improve healthcare outcomes for diabetes patients and to reduce overall costs.
ASHP and NCPA commended the FDA’s decision to postpone the compliance deadline to November 1, 2015.
Despite efforts by law enforcement and increased security measures by many pharmacies, the number of pharmacy robberies across the country increased during the first five months of 2015.
Oregon Gov. Kate Brown has signed legislation that authorizes pharmacists in that state to be paid for clinical services and expands collaborative practice agreements.
Starting next year, the American Society of Health-System Pharmacists will provide review courses and recertification resources for the Board of Pharmacy Specialties.
The Drug Enforcement Administration is using billboards to post the faces of people suspected of looting dozens of pharmacies during Baltimore’s Freddie Gray riots in April.
The St. Louis College of Pharmacy recently announced plans to construct a $40 million, seven-story student center, residence hall, and recreation facility.
The Oregon Board of Pharmacy has ordered the emergency closure of a pharmacy and the suspension of a pharmacist accused of manufacturing marijuana products and dispensing controlled substances without prescriptions.
FDA's revamped REMS website enables users to find what they need and download it more easily.
Under a new law approved two years ago, some pharmacists in California will soon be able to prescribe birth control.
The lawsuit gained new life recently when Guilford denied Walmart’s motion to dismiss it, ruling Nikmanesh had sufficiently addressed the factual allegation deficiencies in an amended complaint.
The former pharmacy director at Beth Israel Medical Center in New York City recently pled guilty to four counts of criminal possession of a controlled substance.
Lakeland, Fla.-based Publix Super Markets is planning to invest $15 million to expand its pharmacy distribution services.
The American Society of Health-System Pharmacists, the American Pharmacists Association, the National Community Pharmacists Association, and the National Alliance of State Pharmacy Associations have asked the FDA to allow more time for pharmacists to comply with the track and trace requirements for “dispensers.”
At the first meeting, stakeholders will explore ways to make naloxone more widely available. At the joint meeting, participants will evaluate post-marketing data for reformulated OxyContin.
Expert tips on attracting and keeping retail pharmacy customers
A potentially dangerous situation was diffused by a quick-thinking pharmacist.
The Drug Enforcement Administration has issued subpoenas to Costco Wholesale Corp. concerning its practices related to dispensing controlled substances.
A targeted intervention at an urban Veterans Affairs Medical Center helped to improve the prescribing practices for elderly veterans discharged from the emergency department
To relieve intractable working conditions, pharmacists will have to join together. It's time to unionize.
CVS announced a $1.9 billion-dollar deal to acquire Target’s more than 1,660 pharmacies and nearly 80 clinics in 47 states.
FDA advisory committee okays two monoclonal antibody formulations in two days for treatment of hypercholesterolemia.
Each option has drawbacks. Bottom line: The ideal choice is the one the patient will actually use.
Is rivaroxaban the best therapeutic option for this patient?
Letters, e-mails, posts, and comments from Drug Topics readers
A groundbreaking bill passes in Washington state, CVS Health to buy Omnivore, FIP in Dusseldorf, and more.
